Reproductive toxicity of ritonavir in male: Insight into mouse sperm capacitation

Since COVID-19 began in 2019, therapeutic agents are being developed for its treatment. Among the numerous potential therapeutic agents, ritonavir (RTV), an anti-viral agent, has recently been identified as an important element of the COVID-19 treatment. Moreover, RTV has also been applied in the dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Eun-Ju, Lee, Woo-Jin, Hwang, Ju-Mi, Bae, Jeong-Won, Kwon, Woo-Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527077/
https://www.ncbi.nlm.nih.gov/pubmed/36198369
http://dx.doi.org/10.1016/j.reprotox.2022.09.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527077/
https://www.ncbi.nlm.nih.gov/pubmed/36198369
http://dx.doi.org/10.1016/j.reprotox.2022.09.008

Ejemplares similares